Rockwood Holdings (ROC) 79.20 $ROC
A2A Letter of Intent for the Brodarevo Hydroelectric Projects in Serbia Expires
Marketwired - Tue Mar 29, 4:25PM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company"
(TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) reports the expiry of the Letter of Intent ("LOI" signed with A2A S.p.A. ("A2A" to complete exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia. The LOI was originally signed in October 2015 and then extended in December 2015, through until February 29, 2016.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Reservoir Capital Corp.: Corporate Update
Marketwired - Fri Jan 22, 3:31PM CST
Reservoir Capital Corp., ("Reservoir" or the "Company" (TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC)announces that Michael Brown has resigned as Director of the Company effective immediately.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Innophos to Appoint Peter T. Thomas and Robert J. Zatta to Board of Directors
PR Newswire - Mon Jan 11, 3:05PM CST
Innophos Holdings, Inc. (NASDAQ: IPHS) ("Innophos" or the "Company" and FrontFour Capital Group LLC ("FrontFour Capital" , a shareholder of Innophos, with ownership of 1.07% of the Company's outstanding shares, today announced that the Company has appointed Peter T. Thomas, Chairman, President and Chief Executive Officer of Ferro Corporation, and Robert J. Zatta, Former Acting Chief Executive Officer and long-time Chief Financial Officer of Rockwood Holdings, Inc., to the Company's Board of Directors, effective immediately. Mr. Thomas and Mr. Zatta will be included in the Company's slate of director nominees for election at the Company's 2016 Annual Meeting. With these changes, the Innophos Board has been expanded to nine directors, eight of whom are independent.
FOE: 14.44 (+0.03), ROC: 79.20 (+0.33), IPHS: 42.66 (+0.40)
Reservoir Extends Letter of Intent for the Brodarevo Hydroelectric Projects in Serbia
Marketwire Canada - Tue Dec 22, 7:00AM CST
Reservoir Capital Corp. ("Reservoir" or the "Company" (TSX VENTURE:REO)(FRANKFURT:ROC)(BERLIN:ROC) is pleased to report that it is has agreed to extend to February 29, 2016, the Letter of Intent ("LOI" with A2A S.p.A. ("A2A" to complete exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Global Orthopedic Biomaterials Market 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Mon Nov 16, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/bw2mc6/global_orthopedic) has announced the addition of the "Global Orthopedic Biomaterials Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. Orthopaedic biomaterials market is expected to grow at a CAGR of 11% for the forecasted period of 2015-2021 The market is segmented on the basis of products, application and biomaterials type. The biomaterials type includes metals and non-metals. Metals include stainless steel, titanium and cobalt alloys; non metals include ceramics, polymers and composites. Application of biomaterials includes orthobiologics, joint replacements, viscosupplementation and others. Products include bone allografts, aligned bone matrix, machined bones, bone morphogenetic protein, synthetic bone substitute and others. The market is driven by high expenditure in the research and development field. New biomaterials are being developed which are more compatible to human body. One of the major issues faced by manufacturers, physicians and patients alike is the biocompatibility of the products. Manufacturers are working on various new biomaterials and developing tissue reengineering techniques. Polymer based biodegradable biomaterials are being produced at a higher volume such as polyglycolic acid and polylactic acids. These polymers can easily be placed, as the implants are removed the callus strength increases. The hardware removal is not necessary therefore reducing the cost. High prevalence of age related lifestyle diseases and increasing number of elderly population is also driving the market. The market is highly competitive and consists of some major player such as Genzyme Corporation, Carpenter Technology Corporation, and Materion Corporation. Ulbrich Stainless Steel & Special Metals, Inc., Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), Ceradyne, Inc., Kyocera Corporation, Bayer, Purac Biomaterials and others. Key Topics Covered: 1. Introduction 2. Market Overview 3. Market Determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical Analysis 8. Company Profiles - Bayer - Biocoat Incorporated - Biocomposites Ltd - Biomet - Cam Bioceramics BV - Carpenter Technology Corporation - Ceradyne, Inc - CeramTec (a subsidiary of Rockwood Holdings Inc) - Collagen Matrix Inc - DePuy Synthes - DSM Biomedical Inc - Etex Corp - Evonik Industries AG - Genzyme Corporation - Heraeus Medical Components - Integra lifesciences Inc - Invibo PEEK biomaterial solutions - Kyocera Corporation - Materion Corporation - Medtronic - NovaBone Products LLC - Osteotech, Inc - Purac Biomaterials - Starch Medical, Inc Landec Corporation - Stryker - Ticona GmbH - Ulbrich Stainless Steel & Special Metals, Inc - Wright Medical Group - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/bw...orthopedic
ZMH: 113.56 (+0.29), KYO: 50.09 (+0.86), CRS: 39.04 (+0.27), MDT: 88.76 (-0.16), LNDC: 10.90 (-0.30), ROC: 79.20 (+0.33), WMGIZ: 1.27 (-0.06), MTRN: 26.50 (-0.19)
Reservoir Signs Letter of Intent With A2A to Partner or Acquire Its Brodarevo Hydroelectric Projects in Serbia
Marketwire Canada - Thu Oct 08, 3:46PM CDT
Reservoir Capital Corp. ("Reservoir" or the "Company" (TSX VENTURE:REO)(FRANKFURT:ROC)(BERLIN:ROC) is pleased to report that is has signed a Letter of Intent ("LOI" with Milan-based utility A2A S.p.A. ("A2A" , to initiate exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia. Under the terms of the agreement, A2A will have until November 24, 2015 to complete this process and negotiate terms for a definitive agreement.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Fitch Rates Albemarle's New Term Loans 'BBB-'
BusinessWire - Wed Sep 16, 10:52AM CDT
Fitch Ratings has assigned a rating of 'BBB-' to Albemarle Corporation's (NYSE: ALB, Albemarle) new $300 million 364-day senior unsecured term loan and new $950 million five-year term loan. Proceeds of the term loans are to be used to finance the redemption of Rockwood Specialties Group, Inc.'s $1.25 billion, 4.625% senior notes due 2020. The term loans have substantially the same covenants as the revolving credit facility. A complete list of ratings follows at the end of this release.
ROC: 79.20 (+0.33), ALB: 85.55 (+0.33)
Reservoir Secures Location Permits for its Brodarevo Hydroelectric Projects in Serbia
Marketwired - Tue Sep 15, 7:03AM CDT
Reservoir Capital Corp. (TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC), ("Reservoir" or the "Company" is pleased to report that is has been granted Location Permits for both the Brodarevo 1 and Brodarevo 2 dam sites, reservoirs and accompanying facilities; the final step prior to applying for the Building Permits.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Albemarle moving corporate headquarters to Charlotte
AP - Tue Aug 25, 11:53AM CDT
NEW YORK (AP) — Albemarle is moving its corporate headquarters and performance chemicals business from Baton Rouge, Louisiana, to Charlotte, North Carolina.
ROC: 79.20 (+0.33), ALB: 85.55 (+0.33)
Albemarle provides update on realignment of global business units
PR Newswire - Mon Apr 27, 4:03PM CDT
Albemarle Corporation (NYSE: ALB) today provided an update to the previously announced realignment of its global business units resulting from its acquisition of Rockwood Holdings, Inc. in January. The company has announced its senior leadership team and business and functional leaders consistent with the realignment and will announce its first quarter operating results pursuant to the new structure.
ALB: 85.55 (+0.33), ROC: 79.20 (+0.33)
Reservoir Receives New Energy Permits for Its Brodarevo Hydroelectric Projects in Serbia
Marketwired - Wed Mar 25, 6:01AM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company" (TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) is pleased to report that the Ministry of Mining and Energy of the Republic of Serbia, has granted new Energy Permits for the Company's Brodarevo 1 and Brodarevo 2 hydroelectric projects on the Lim River in southwest Serbia. The permits are valid for a period of three years and may be renewed for an additional year under certain circumstances.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Reservoir Receives Location Permit for its Brodarevo-2 Hydroelectric Project in Serbia
Marketwired - Mon Mar 16, 6:02AM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company" (TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) is pleased to report that the Ministry of Infrastructure and Energy of the Republic of Serbia, has granted the Location Permit for the Company's 33.1 Megawatt ("MW" Brodarevo 2 hydroelectric project on the Lim River in southwest Serbia. The permit is valid for one year and allows the Company to undertake preparatory work on the project, encompassing the temporary passage over the river, site access roads and river diversion.
ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
A2A Letter of Intent for the Brodarevo Hydroelectric Projects in Serbia Expires
Marketwired - Tue Mar 29, 4:25PM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company"
(TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) reports the expiry of the Letter of Intent ("LOI" signed with A2A S.p.A. ("A2A" to complete exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia. The LOI was originally signed in October 2015 and then extended in December 2015, through until February 29, 2016. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Reservoir Capital Corp.: Corporate Update
Marketwired - Fri Jan 22, 3:31PM CST
Reservoir Capital Corp., ("Reservoir" or the "Company"
(TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC)announces that Michael Brown has resigned as Director of the Company effective immediately. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Innophos to Appoint Peter T. Thomas and Robert J. Zatta to Board of Directors
PR Newswire - Mon Jan 11, 3:05PM CST
Innophos Holdings, Inc. (NASDAQ: IPHS) ("Innophos" or the "Company"
and FrontFour Capital Group LLC ("FrontFour Capital" , a shareholder of Innophos, with ownership of 1.07% of the Company's outstanding shares, today announced that the Company has appointed Peter T. Thomas, Chairman, President and Chief Executive Officer of Ferro Corporation, and Robert J. Zatta, Former Acting Chief Executive Officer and long-time Chief Financial Officer of Rockwood Holdings, Inc., to the Company's Board of Directors, effective immediately. Mr. Thomas and Mr. Zatta will be included in the Company's slate of director nominees for election at the Company's 2016 Annual Meeting. With these changes, the Innophos Board has been expanded to nine directors, eight of whom are independent. FOE: 14.44 (+0.03), ROC: 79.20 (+0.33), IPHS: 42.66 (+0.40)
Reservoir Extends Letter of Intent for the Brodarevo Hydroelectric Projects in Serbia
Marketwire Canada - Tue Dec 22, 7:00AM CST
Reservoir Capital Corp. ("Reservoir" or the "Company"
(TSX VENTURE:REO)(FRANKFURT:ROC)(BERLIN:ROC) is pleased to report that it is has agreed to extend to February 29, 2016, the Letter of Intent ("LOI" with A2A S.p.A. ("A2A" to complete exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Global Orthopedic Biomaterials Market 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Mon Nov 16, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/bw2mc6/global_orthopedic) has announced the addition of the "Global Orthopedic Biomaterials Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. Orthopaedic biomaterials market is expected to grow at a CAGR of 11% for the forecasted period of 2015-2021 The market is segmented on the basis of products, application and biomaterials type. The biomaterials type includes metals and non-metals. Metals include stainless steel, titanium and cobalt alloys; non metals include ceramics, polymers and composites. Application of biomaterials includes orthobiologics, joint replacements, viscosupplementation and others. Products include bone allografts, aligned bone matrix, machined bones, bone morphogenetic protein, synthetic bone substitute and others. The market is driven by high expenditure in the research and development field. New biomaterials are being developed which are more compatible to human body. One of the major issues faced by manufacturers, physicians and patients alike is the biocompatibility of the products. Manufacturers are working on various new biomaterials and developing tissue reengineering techniques. Polymer based biodegradable biomaterials are being produced at a higher volume such as polyglycolic acid and polylactic acids. These polymers can easily be placed, as the implants are removed the callus strength increases. The hardware removal is not necessary therefore reducing the cost. High prevalence of age related lifestyle diseases and increasing number of elderly population is also driving the market. The market is highly competitive and consists of some major player such as Genzyme Corporation, Carpenter Technology Corporation, and Materion Corporation. Ulbrich Stainless Steel & Special Metals, Inc., Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), Ceradyne, Inc., Kyocera Corporation, Bayer, Purac Biomaterials and others. Key Topics Covered: 1. Introduction 2. Market Overview 3. Market Determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical Analysis 8. Company Profiles - Bayer - Biocoat Incorporated - Biocomposites Ltd - Biomet - Cam Bioceramics BV - Carpenter Technology Corporation - Ceradyne, Inc - CeramTec (a subsidiary of Rockwood Holdings Inc) - Collagen Matrix Inc - DePuy Synthes - DSM Biomedical Inc - Etex Corp - Evonik Industries AG - Genzyme Corporation - Heraeus Medical Components - Integra lifesciences Inc - Invibo PEEK biomaterial solutions - Kyocera Corporation - Materion Corporation - Medtronic - NovaBone Products LLC - Osteotech, Inc - Purac Biomaterials - Starch Medical, Inc Landec Corporation - Stryker - Ticona GmbH - Ulbrich Stainless Steel & Special Metals, Inc - Wright Medical Group - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/bw...orthopedic
ZMH: 113.56 (+0.29), KYO: 50.09 (+0.86), CRS: 39.04 (+0.27), MDT: 88.76 (-0.16), LNDC: 10.90 (-0.30), ROC: 79.20 (+0.33), WMGIZ: 1.27 (-0.06), MTRN: 26.50 (-0.19)
Reservoir Signs Letter of Intent With A2A to Partner or Acquire Its Brodarevo Hydroelectric Projects in Serbia
Marketwire Canada - Thu Oct 08, 3:46PM CDT
Reservoir Capital Corp. ("Reservoir" or the "Company"
(TSX VENTURE:REO)(FRANKFURT:ROC)(BERLIN:ROC) is pleased to report that is has signed a Letter of Intent ("LOI" with Milan-based utility A2A S.p.A. ("A2A" , to initiate exclusive negotiations and due diligence on the Company's Brodarevo hydroelectric power project ("HPP" in southern Serbia. Under the terms of the agreement, A2A will have until November 24, 2015 to complete this process and negotiate terms for a definitive agreement. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Fitch Rates Albemarle's New Term Loans 'BBB-'
BusinessWire - Wed Sep 16, 10:52AM CDT
Fitch Ratings has assigned a rating of 'BBB-' to Albemarle Corporation's (NYSE: ALB, Albemarle) new $300 million 364-day senior unsecured term loan and new $950 million five-year term loan. Proceeds of the term loans are to be used to finance the redemption of Rockwood Specialties Group, Inc.'s $1.25 billion, 4.625% senior notes due 2020. The term loans have substantially the same covenants as the revolving credit facility. A complete list of ratings follows at the end of this release.
ROC: 79.20 (+0.33), ALB: 85.55 (+0.33)
Reservoir Secures Location Permits for its Brodarevo Hydroelectric Projects in Serbia
Marketwired - Tue Sep 15, 7:03AM CDT
Reservoir Capital Corp. (TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC), ("Reservoir" or the "Company"
is pleased to report that is has been granted Location Permits for both the Brodarevo 1 and Brodarevo 2 dam sites, reservoirs and accompanying facilities; the final step prior to applying for the Building Permits. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Albemarle moving corporate headquarters to Charlotte
AP - Tue Aug 25, 11:53AM CDT
NEW YORK (AP) — Albemarle is moving its corporate headquarters and performance chemicals business from Baton Rouge, Louisiana, to Charlotte, North Carolina.
ROC: 79.20 (+0.33), ALB: 85.55 (+0.33)
Albemarle provides update on realignment of global business units
PR Newswire - Mon Apr 27, 4:03PM CDT
Albemarle Corporation (NYSE: ALB) today provided an update to the previously announced realignment of its global business units resulting from its acquisition of Rockwood Holdings, Inc. in January. The company has announced its senior leadership team and business and functional leaders consistent with the realignment and will announce its first quarter operating results pursuant to the new structure.
ALB: 85.55 (+0.33), ROC: 79.20 (+0.33)
Reservoir Receives New Energy Permits for Its Brodarevo Hydroelectric Projects in Serbia
Marketwired - Wed Mar 25, 6:01AM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company"
(TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) is pleased to report that the Ministry of Mining and Energy of the Republic of Serbia, has granted new Energy Permits for the Company's Brodarevo 1 and Brodarevo 2 hydroelectric projects on the Lim River in southwest Serbia. The permits are valid for a period of three years and may be renewed for an additional year under certain circumstances. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
Reservoir Receives Location Permit for its Brodarevo-2 Hydroelectric Project in Serbia
Marketwired - Mon Mar 16, 6:02AM CDT
Reservoir Capital Corp., ("Reservoir" or the "Company"
(TSX VENTURE: REO)(FRANKFURT: ROC)(BERLIN: ROC) is pleased to report that the Ministry of Infrastructure and Energy of the Republic of Serbia, has granted the Location Permit for the Company's 33.1 Megawatt ("MW" Brodarevo 2 hydroelectric project on the Lim River in southwest Serbia. The permit is valid for one year and allows the Company to undertake preparatory work on the project, encompassing the temporary passage over the river, site access roads and river diversion. ROC: 79.20 (+0.33), REO.VN: 0.080 (unch)
